Evidence map›Paper›PMID 41848822›Full record

ArticleACS applied materials & interfaces2026

Nickel Single-Atom Nanozyme for Multimodal Cancer Therapy.

Jiwon Woo, Hojeong Shin, Seongin Hong, Hyeonwoo Cho, Byung Hee Hong, Yun Jeong Hwang, Dal-Hee Min

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiwon WooDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0009-0003-6416-301X
Hojeong ShinDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0001-5895-0955
Seongin HongDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Hyeonwoo ChoDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0009-0000-5600-4180
Byung Hee HongDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0001-8355-8875
Yun Jeong HwangDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0002-0980-1758
Dal-Hee MinDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0001-8623-6716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nickel has recently emerged as a promising catalytic center for single-atom catalysts, owing to its biological relevance, redox versatility, and favorable coordination chemistry. Herein, we report the synthesis of a multifunctional nanozyme (Ni/PEG-FA) comprising atomically dispersed nickel sites anchored on a nitrogen-doped carbon support. The nanozyme is functionalized with poly(ethylene glycol) to improve colloidal stability and biocompatibility, and further conjugated with folic acid to enable the selective targeting of cancer cells overexpressing folate receptors. Ni/PEG-FA exhibits dual enzyme-mimicking activity, catalyzing both peroxidase-like and superoxide dismutase-like reactions for efficient reactive oxygen species generation under physiological conditions. In addition, Ni/PEG-FA shows strong photothermal conversion upon near-infrared laser irradiation, enabling effective thermal ablation of tumor cells. In vitro and in vivo evaluations demonstrate that Ni/PEG-FA elicits synergistic antitumor effects by combining catalytic oxidative stress with photothermal therapy, with minimal systemic toxicity. These findings underscore the potential of Ni-based single-atom nanozymes as a safe and effective platform for reactive oxygen species-powered cancer therapy.

Indexed as

Antineoplastic AgentsNeoplasmsNickelAnimalsCatalysisCell Line, TumorFolic AcidHumansMicePhotothermal TherapyPolyethylene GlycolsReactive Oxygen SpeciesAntineoplastic AgentsFolic AcidNickelPolyethylene GlycolsReactive Oxygen Speciescancer therapynanozymephotothermal conversionreactive oxygen speciessingle-atom catalystsynergistic therapy

Identifiers

PMID41848822
PMCPMC13051463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.